This week's Guest Voice is Richard Bayliss, who talks about three coping tools he's found useful in living with sickle cell ...

C-reactive protein levels significantly higher during follicular vs luteal phase, which may contribute to pattern of painful vaso-occlusive events. HealthDay News — For adults with sickle cell ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

For those battling sickle cell disease, pain and fear are tragically routine, yet a significant scientific advancement offers newfound optimism for the UK's 17,500 affected individuals.

Period-driven inflammation could influence the risk of pain events among women with sickle cell disease Levels of C-reactive protein increase among women with sickle cell disease during the first ...

While both sickle cell trait and sickle cell disease involve mutations in the haemoglobin gene, they are fundamentally different in terms of symptoms, severity, and impact on daily life.

People with sickle cell disease are immunocompromised, which means they have an increased risk of infection. For this reason, immunizations are an important part of complete sickle cell care. This ...

This is frequently the case in people with sickle cell disease, the vast majority of whom have African ancestry. These transfusions initially make the transfused blood last for a shorter time than ...

wiping out teams working on research about adults with cognitive disabilities and sickle cell disease. Work likely to be halted by the cuts includes the collection of data for studying Americans ...

Scientists at Raman Research Institute (RRI) have developed an affordable electro-fluidic device that aids in preliminary screening of Sickle Cell Disease (SCD). According to RRI, the innovative ...

NHS patients with sickle cell disease can now benefit from a groundbreaking gene-editing treatment that holds the potential to cure the condition. The one-off gene therapy, exagamglogene autotemcel ...

Get Instant Summarized Text (Gist) Research has identified the protein QRICH1 as a potential target for modulating T-cell activation in cancer and autoimmune diseases. QRICH1 acts as a partial ...